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ABSTRACT 
According to the CDC, the most recent estimate of the prevalence of autism spectrum disorders 
is 1 in 68. The continuing increase in prevalence over the last several years has professionals 
across disciplines searching for the true etiology of the disorder and for effective treatments to 
address this public health problem. An important caveat to acknowledge is that the CDC’s 
prevalence estimates for autism are based upon a sentinel surveillance system that experiences 
great variability between sites. In order for a more population-based surveillance system to be 
implemented, a standardized set of data would need to be collected across the entire population. 
This paper will examine what kind of data would be available from the electronic health records 
of behavioral health treatment agencies using data from an autism treatment agency in 
Southwestern Pennsylvania and reviews Pennsylvania’s current efforts to estimate the burden of 
autism throughout the state. This paper focuses on the public health problem of accurate 
assessment of disease burden to allow for adequate resource allocation at a state policy level to 
care for affected residents.  
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1.0  INTRODUCTION 
Data from surveillance systems inform several aspects of public health activities. Surveillance is 
defined as “the ongoing and systematic collection, analysis, and interpretation of health data in 
the process of describing and monitoring a health event.”1 For infectious diseases, surveillance is 
an incredibly valuable tool for detecting epidemics, testing hypotheses about the source of 
infection, and evaluating control measures that are put into place.2 Surveillance systems are also 
a useful tool in the management of chronic conditions and developmental disabilities such as 
Autism Spectrum Disorder. In these cases, surveillance systems can help public health 
professionals estimate the prevalence of the problem, detect increases or decreases in prevalence 
over time, and document the distribution of the cases in various locations.2 Using this 
information, policy makers can make informed decisions about resource distribution for 
prevention and treatment and researchers can cross-reference this information with other data 
sets to conduct research into etiology and intervention effectiveness.2 There are a variety of 
methods utilized to capture health data for surveillance activities such as active surveillance, 
where staff of the entity managing the surveillance system reach out to health care providers or 
the general population to obtain health data, or passive surveillance where health care providers 
are responsible for providing information for surveillance activities, often through electronic 
reporting.3 A case that is included in the surveillance system can be based on a diagnosis made 
by a health care practitioner or in the case of syndromic surveillance, based on evidence of a 
cluster of symptoms consistent with the disease being monitored.3  
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The Centers for Disease Control and Prevention (CDC) currently conduct surveillance for 
Autism Spectrum Disorders (ASDs) using an active, syndromic surveillance system. The data 
from this system indicates that the prevalence of (ASDs) has been increasing since 2002.4 The 
designated population for CDC surveillance for ASDs is based on the Autism and 
Developmental Disabilities Monitoring Network (ADDM), which contains programs within 
fourteen communities that are funded by the CDC for active record review.5 Trained reviewers 
look at historical comprehensive professional evaluations in records for evidence of behaviors 
consistent with the ASD diagnosis according to the DSM-IV-TR criteria.6 In 2008, the record 
review revealed a prevalence of 1 in 88 or 11.3 per 1,000 children for children who were eight 
years of age within the review year.4 Currently, the CDC is reviewing records from 2010 to 
abstract an updated prevalence estimate of autism.5 Children are not required to have a diagnosis 
of autism to be considered as a case in this surveillance system, and in 2008, only 79% of cases 
had a documented diagnosis of autism.7 While this system picks up diagnoses that wouldn’t be 
reported if the CDC relied on only diagnosed cases of ASDs, one study estimated that the CDC 
tracking system is missing 12 out of every 177 cases of autism.8 
ASDs are a group of developmental disabilities that are marked by a group of social 
impairments that have a significant impact on an individual’s day-to-day functioning.6 To be 
included as a case in CDC’s current surveillance system, the individual must have documented 
symptoms that are consistent with one of the three types of Autism Spectrum Disorder based on 
the criteria defined in the current Diagnostic and Statistical Manual (DSM-IV-TR).7 The first 
diagnosis that is included is Autistic Disorder, which is characterized by impairments in social 
interaction and communication that is also accompanied by restricted interests and stereotyped 
patterns of behavior.6 To be considered a case of Autistic Disorder, symptoms must appear prior 
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to age three.6 Asperger’s Disorder is also included in ASD cases, and is characterized by a 
similar social impairment and restricted interests with repetitive behavior, but individuals with 
Asperger’s do not have the delay in language seen in Autistic Disorder.6 The third diagnosis 
included is Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) for 
individuals that have an impairment in social interaction and either communication skills deficits 
or restricted interests.6 The CDC also includes Atypical Autism in the PDD-NOS category for 
individuals that meet the criteria for Autistic Disorder but don’t have symptom onset prior to the 
age of three.6 
There is some evidence that a portion of the recent increase in the prevalence of autism is 
related to factors such as increased screening and changes in diagnostic criteria. One study did a 
record review of children who were evaluated for autism in the 1980s using the DSM-IV-TR 
case definition and found that 59% of the cases that were considered “not autistic” using the 
DSM-III criteria met the case definition using the DSM-IV-TR definition.9 The case definition 
for ASDs in clinical settings will soon change again. In May 2013, the American Psychiatric 
Association released an update to the Diagnostic and Statistical Manual of Mental Disorders with 
the DSM-5.10 Instead of having three separate diagnoses, the DSM 5 contains a single Autism 
Spectrum Disorder diagnosis that requires that symptoms appear in early childhood and rates on 
a scale of one to three based on the level of support needed.11-12 Preliminary studies indicate that 
the change in diagnostic criteria may result in a decrease in the number of individuals diagnosed 
with ASD. A recent study by Huerta, et al. concluded that 91% of children with a PDD-NOS 
diagnosis would maintain the Autistic Disorder diagnosis with the DSM-5 and that the new 
criteria will provide greater specificity for true cases of Autistic Disorder.13 The CDC has not yet 
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published if they will adopt a new case definition based on the DSM 5, so the impact of this 
change on prevalence estimates is currently unknown.   
Since the CDC’s current surveillance activities only focus on a limited portion of the 
United States’ population, the prevalence numbers that are published cannot be generalized to 
the entire population. Prevalence of autism varied drastically from site to site in the 2008 review; 
the lowest prevalence was in Alabama with a prevalence of 4.8 per 1,000 while the prevalence in 
Utah was the highest at 21.2 per 1,000.7 A portion of this variation was accounted for by the type 
of records the reviewers were able to access. Overall, prevalence was higher in ADDM sites that 
had access to educational and health records.7 While accuracy of numbers is very important for 
determining the true burden of disease in society, the wide variation of prevalence by location 
makes it difficult to estimate what prevalence looks like in areas that do not have ADDM sites. 
To expand the current surveillance system to a wider geographic area would increase the expense 
of surveillance, but it would provide some important data for public health professionals. There 
is some evidence that environmental exposure to hazardous air pollution or the prescription 
drugs thalidomide and valproic acid during pregnancy or early childhood could affect the 
prevalence of autism.14-15 A population based surveillance system could allow for cross-
referencing of autism prevalence with presence of environmental exposures to further test these 
hypotheses or to create new ones. Public Health professionals could also use this data to help 
support the deployment of resources for early intervention and treatment. Since prevention is not 
possible for this disorder because of the unknown etiology, resources for early intervention are 
important for affecting outcomes for children with autism. Moving to a population-based 
surveillance system would likely result in an underestimation of the true burden of ASDs, but it 
would capture the important variability of case distribution across the nation and provide local 
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and state governments with information to help distribute resources and address the needs of the 
population they serve.   
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1.1 AUTISM IN PENNSYLVANIA 
The commonwealth of Pennsylvania has shown an interest in quantifying the burden of ASDs in 
the population. While the CDC has an ADDM site in Philadelphia County that estimated that 
13.3 per 1,000 were living with autism,16 the commonwealth created an initiative to gain a more 
comprehensive picture. The Pennsylvania Department of Public Welfare (DPW) sponsored a 
study to determine an unduplicated count of individuals in Pennsylvania living with ASD who 
were accessing any publicly funded system.17 The census report used administrative records 
from the Pennsylvania Department of Education (PDE) and the Department of Public Welfare 
(DPW) in calendar year 2005.17 Data were collected from multiple offices in DPW including the 
Office of Mental Health and Substance Abuse Services (OMHSAS), Office of Developmental 
Programs (ODP), Office of Social Programs (OSP), and the Office of Medical Assistance 
Programs (OMAP).17 DPW used ICD-10 codes for autism (299.xx) to identify cases and then 
merged data across all offices using name, date of birth, social security number, and Client 
Information System number to attain an unduplicated count.17 PDE used primary and secondary 
disability categories of autism or receipt of “autistic services” to identify cases and then matched 
their data to DPWs data using first name, last name, date of birth, and social security number to 
obtain a final unduplicated count.17 
The final census report showed that there are a higher number of cases in Allegheny 
County (2,235) than in Philadelphia (2,142), where the CDC has their ADDM site for the 
national surveillance.17 This could be an indication that prevalence of autism is actually higher in 
Allegheny County or that more individuals with autism are accessing services in the home, 
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school, or community. The report also indicated that the highest prevalence was noted in Warren, 
Pike, Clearfield, Mercer, and Monroe counties but note that diagnostic expertise and low 
population numbers in some rural counties could account for this difference.17 The report 
determined that the average age of individuals being served with autism in 2005 was 11.3 years 
with 80.3% of individuals being male.17 Race classification was consistent with expected 
numbers based on Pennsylvania census data, with 81% of individuals with autism being white, 
12% were black, 5% were Hispanic, and 2% were Asian/Pacific Islander.17     
From a fiscal perspective, the number of individuals with autism in a given area is 
valuable information when budgeting for their health care and educational needs. According to 
the CDC, individuals with autism’s health care costs are 4.1-6.2 higher than those without ASD 
with the additional need of intensive behavioral interventions for children that cost $40,000-
60,000 per year.4 In Allegheny County, a non-profit agency called Allegheny Health Choices, 
Inc. provides demographic and cost reports for behavioral health claims processed in Allegheny 
County for individuals enrolled in the Medicaid managed care plan. In 2012, 18% of all children 
who used behavioral health services were treated for autism spectrum disorders.18 The average 
cost of treatment per user was $9,254 as compared to an average cost of $3,815 for treatment of 
ADHD, the most common diagnosis for children treated in Allegheny County in 2012.18  
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2.0  AUTISM IN AGENCY A 
In order for a passive surveillance system to be successful, professionals who are diagnosing 
autism must use a standard case definition and collect and report data in a standardized fashion. 
To determine what information could be captured from individual provider agencies, the author 
was granted access to a behavioral health agency’s (Agency A) electronic medical record system. 
The agency collected a variety of demographic information from individuals with autism, parents 
of children with autism, or other professionals, such as case managers, that worked with the 
individuals when they called to express their interest in receiving services. The individual’s 
diagnosis would be obtained and entered into the medical record prior to the start of services.  
 The data below represents individuals with a diagnosis of autism who either contacted 
Agency A between April 2010 and March 2013 or had someone contact Agency A on their 
behalf expressing an interest in services. At this point of contact, individuals and their 
demographic information is entered into the agency health record. Data that is presented by year 
is based on the date of contact with Agency A. These individuals may or may not have received 
health care treatment with Agency A.  
Agency A has three office locations that are primarily designated to serve children with 
autism. The red circles on Figure 1 indicate each of these office locations and the concentration 
of individuals contacting the agency about services. The finding that the highest number of cases 
is concentrated around the office locations is most likely explained by the need for individuals 
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served to come to the office locations to receive services or have staff from those offices willing 
to travel to serve these individuals in their homes. It is not likely a true picture of the prevalence 
of autism in each of those zip codes.   
 
Figure 1. Agency A ASD Cases by Zip Code 
 There were 392 new electronic records created for individuals with Autism created 
between April 2010 and March 2011. The number of individuals entered into the health record 
database fell drastically in the following years to 225 and 229 in 2011 and 2012 respectively 
(Figure 2). Some of this variation might be explained by the transition of Agency A to an EMR 
in April of 2010. There was a need to have all individuals currently being treated electronically 
imported into the new EMR so that clinicians could document their work. The majority of 
individuals were successfully imported into the system on March 17, 2010. These 740 
individuals were removed from the analysis since their contact with the agency was prior to the 
timeframes included in this analysis. However, some individuals being served were not included 
in the initial import were manually entered into the new EMR. Manual entry occurred on all 
different dates so these individuals could not be reliably removed from the analysis.  
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 Figure 2. Number of ASD Cases Referred to Agency A by Year 
The majority of individuals received a diagnosis of Pervasive Developmental Disorder, 
Not Otherwise Specified (PDD-NOS). This diagnosis accounted for 81.6% of total new 
individuals entered into the health record in 2010 (Figure 3). Overall, PDD-NOS accounted for 
81% of all of the new individuals entered into the health record (Figure 4). Since a diagnosis of 
PDD-NOS does not require a child to display the deficits in communication and the restricted 
interests that are a part of the Autistic Disorder diagnostic criteria, it is a diagnosis that would 
apply to a larger number of children. Another potential reason for high number of PDD-NOS 
diagnoses seen here could be attributed to the services provided by Agency A. One of the most 
highly attended treatment programs is a social skills group that requires that attendees have some 
proficiency in their communication skills and limited stereotypical behavior in order to receive 
the full benefit of the program. Based on the diagnostic criteria for Autistic Disorder, it is 
expected that this program would attract individuals with a diagnosis of PDD-NOS or Asperger’s 
Disorder instead.  
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 Figure 3. Subtypes of ASD Diagnosis by Year 
 
Figure 4. Subtypes of ASD Diagnosis  
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 Consistent with CDC statistics for nationwide gender distribution of autism, 81% of 
individuals who contacted Agency A who had autism were for males (Figure 5). 
 
Figure 5. Gender Distribution for Individuals with ASD 
 The average age of children when their parent or case  manager contacted Agency A for 
services was 11.1 years of age and the median age was also 11 years old. As seen in Figure 6, 
there are also a large number of eight year olds referred for services which is consistent with 
studies that show most children with developmental disabilities have been diagnosed and 
identified for services by age eight.5  
Male81%
Female19%
Gender of Individuals with Autism Referred to 
Agency from April 2014 to March 2013
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 Figure 6. Ages of Individuals with ASD in Agency A 
Interestingly, the children’s age at the time Agency A was contacted for services 
illustrates a trend of referral for service at a younger age (Figure 7). The trend potentially could 
represent an increased awareness in the community of the benefits of identifying autism and 
obtaining treatment as early as possible to maximize the benefits to treatment. Agency A also 
started offering diagnostic evaluations in May of 2012. This most likely accounted for the large 
increase seen in the percentage of 2-4 year olds that contacted Agency A for services because the 
symptoms of autism begin to become apparent around 2 years of age.6  
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 Figure 7. Ages of Individuals with ASD in Agency A by Year 
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Consistent with the Pennsylvania Autism Census report, the majority of individuals with 
autism who contacted Agency A between 2010 and 2013 identified themselves as 
White/Caucasian (Figure 8). Some of this data is incomplete as indicated by the ‘missing’ and 
‘not known at this time’ categories. Both of these categories represent missing information, and 
the differing classifications represent a process change that made the race field a required field 
when entering a new individual into the system. The missing category represents when the field 
was blank.  
 
Figure 8. Race of Individuals with ASD in Agency A  
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The following table illustrates the county-specific demographic information based on the 
PA Autism Census Report and the demographic information from Agency A. There were 22 
observations from Agency A that were missing the county designation and are placed at the 
bottom of the table. The number of cases identified in Agency A accounts for a fairly substantial 
percentage of all of the cases identified through the PA Autism Census Report, ranging from 
11% of all cases in Westmoreland County to 28% of all cases in Allegheny County. The race and 
age distributions follow the same patterns, indicating that using treatment agency data could be a 
viable source for a surveillance system.  
Table 1. Comparison of Agency A ASD Cases and Demographics to Surrounding Counties Data from the PA 
Autism Census Report 
 
County/ Agency # of Cases Rate Race  Age Gender  
(% male) 
Allegheny 2,23415 18.08 per 
10,00015 
White                 77.6%  
Black                 15.1%   
Asian/NA/PI      1.2%  
Hispanic            0.5% 
Missing             5.6% 15 
0-4 yrs.:             15.9% 
5-12 yrs.:           54.5% 
13-17 yrs.:         17.5% 
18-20 yrs.:           4.4% 
21+ yrs.:            7.7%15 
80.3%15 
Agency A (Allegheny) 624 N/A White                71.2%  
Black                 10.9%  
Asian/NA           1.6%  
Declined/Other   4.8% 
Missing             11.5%  
0-4 yrs.:              6.6% 
5-12 yrs.:          57.2% 
13-17 yrs.:        26.4% 
18-20 yrs.:         8.5% 
21+ yrs.:            1.3% 
81.3% 
Butler 31715 17.41 per 
10,00015 
White                 97.5%  
Black                  0.9%  
Asian/ NA/PI      0.6% 
Hispanic              0.3% 
Missing              0.6%15 
0-4 yrs.:             12.6% 
5-12 yrs.:           60.3% 
13-17 yrs.:         15.8% 
18-20 yrs.:           3.8% 
21+ yrs.:            7.6%15 
83.6%15 
Agency A (Butler) 53 N/A White                  85% 
Declined            1.9%  
Missing             13.2%  
 
0-4 yrs.:              1.9% 
5-12 yrs.:           66.0% 
13-17 yrs.:         26.4% 
18-20 yrs.:          5.7% 
21+ yrs.:               0% 
77.4% 
Washington 30815 14.92 per 
10,00015 
White                 92.5%  
Black                   4.9%  
Asian/NA/PI        0.6% 
Hispanic               0.3% 
Missing              1.6%15 
0-4 yrs.:             18.6% 
5-12 yrs.:           52.6% 
13-17 yrs.:         18.3% 
18-20 yrs.:           3.3% 
21+ yrs.:            7.2%15 
79.2%15 
Agency A 
(Washington) 
68 N/A White               75.0% 
Black                 2.9% 
Declined/ Other    4.4% 
Missing              16.2% 
0-4 yrs.:              7.4% 
5- 12 yrs.:         51.5% 
13-17 yrs.:        32.4% 
18-20 yrs.:        5.9% 
83.8% 
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 21+ yrs.:            2.9% 
Westmoreland 65815 17.90 per 
10,00015 
White                 93.6% 
Black                  3.6% 
Asian/ NA/ PI     0.2% 
Missing             2.6%15 
0-4 yrs.:             15.7% 
5-12 yrs.:           56.7% 
13-17 yrs.:         15.9% 
18-20 yrs.:          4.0% 
21+ yrs.:            7.8%15 
80.2%15 
Agency A 
(Westmoreland) 
73 N/A White                 76.7% 
Asian                   1.8% 
Declined              1.8% 
Missing              20.5% 
 
0-4 yrs.:              4.1% 
5-12 yrs.:           46.6% 
13-17 yrs.:        34.2% 
18-20 yrs.:        11.0% 
21+ yrs.:             4.1% 
75.3% 
Agency A (county 
information missing) 
22 N/A White                 68.2% 
Black                  9.1% 
Asian                  4.5% 
Other                 13.6% 
Missing               4.5% 
0-4 yrs.:             13.6% 
5-12 yrs.:           50.0% 
13-17 yrs.:         27.3% 
18-20 yrs.:          0.0% 
21+ yrs.:            9.1% 
86.4% 
 
A major limitation of the data presented in this paper is that it is not representative of the 
entire population of individuals with ASDs, only individuals referred to Agency A. Agency A 
provides treatment to individuals with autism in Southwestern Pennsylvania. The data from this 
agency cannot be generalized to the larger population because the agency only provides 
treatment to children and adolescents ages 2-21 and only began to provide services to adults in 
January of 2012.  
 
  
Table 1 Continued 
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2.1 DISCUSSION 
The ability of autism treatment agencies to collect the type of information presented above could 
be the basis for a population based, passive surveillance system. While it would be more costly 
to implement this type of surveillance, the variances seen in the county-level data could be 
incredibly valuable for further research and evaluation in this highly prevalent and expensive 
public health issue. The mandatory use of Electronic Medical Records and the requirements put 
forth for meaningful use could help to ensure that a standardized set of data is captured and 
reported by all treatment agencies. Additionally, Electronic Medical Records usually have the 
capability to provide an export of defined fields that could be used for public health activities 
such as surveillance. Using a similar model for other reportable diseases, the provider could 
report identified cases for all children with an ASD diagnosis that turned 8 years of age within a 
given year to a local health department.  
However, a major drawback to implementing a surveillance system based on treatment 
agency data would be that children with autism often obtain multiple services at a time and often 
use different agencies to obtain these services. For example, a common prescription for a child 
with autism would be to obtain speech therapy, Behavioral Health Rehabilitation Services 
(BHRS) which is a community based therapeutic service, and a social skills group. A child could 
receive speech therapy from the Children’s Institute, BHRS from Family Behavioral Resources, 
and attend a social skills group from Wesley Spectrum Services. Because of the large number of 
autism treatment providers in Pennsylvania, obtaining an unduplicated count of individuals with 
autism could become fairly complicated using individual treatment provider data. With the 
Department of Public Welfare providing oversight of all of these treatment agencies, the 
department will have information on all of these children unless their families self-pay for 
 18 
services or use only commercial insurance. Self-pay and commercial-only funding is not a 
common situation because in Pennsylvania, almost all children with an autism diagnosis are 
eligible to receive Medicaid without having to consider parental income when determining 
benefit eligibility. For this reason, the methodology used for the PA Autism Census Report 
would provide an infrastructure for a surveillance system that would offer more simplicity than 
using data from individual treatment providers, with a minimal trade-off for the sensitivity of the 
system.   
2.2 CONCLUSION 
Pennsylvania is continuing to fund activities to enumerate the number of individuals 
living with autism in the state. In 2013, the Autism Services, Education, Resources, and Training 
Collaborative (ASERT), a statewide initiative that is funded by the Bureau of Autism Services 
which is part of DPW, began work to update the findings of the 2005 PA Autism Census 
Report.19 Using data for individuals receiving services in 2011, ASERT provided an updated 
count of individuals with ASD receiving services from DPW and PDE, and added the additional 
sources of data from the Office of Vocational Rehabilitation (OVR) and Department of 
Corrections and the Pennsylvania Commission on Crime and Delinquency.20  
To transition to a proper surveillance system, the state would need to establish a narrower 
case definition for autism. The case definition should include children residing in Pennsylvania 
that turned eight years of age within the given surveillance year and are accessing services 
through DPW, PDE, OVR, or the Department of Corrections with a ICD-10 diagnosis of autism 
or education disability category of autism in order to be able to compare the data with national 
 19 
trends. Though the methods for collection are slightly different, the CDC chose eight year olds 
for their case definition because that is the age children are most likely to access services so 
discrepancies might be minimal.5  
To obtain an unduplicated count of cases, ASERT could gather the data from PDE 
annually. The information collected by DPW is protected under the Health Insurance Portability 
and Accountability Act (HIPAA)21 and the Family Education Rights and Privacy Act (FERPA) 
protects the information collected by PDE.22 Since HIPAA allows for protected health 
information to be disclosed for public health activities and FERPA does not, DPW will need to 
continue to send information to PDE so they can use the name, social security number, and date 
of birth to identify and remove duplicates using the same process that was completed for the PA 
Autism Census Report. ASERT is already analyzing and reporting on the update to the PA 
Autism Census Report so they could also analyze and report on the prevalence numbers captured 
by the surveillance system. Due to the fact that autism is a life-long disability, and does not 
require immediate action that is needed with some infectious diseases, the passive, occasional 
reporting will be appropriate for this surveillance system.3 Annual reporting will also support one 
of the surveillance system’s main goals of assisting policy makers with distributing resources if 
the data were available for the annual state budgeting process.  
Individuals who are not receiving services from any of these systems will not be included 
in this system so it will likely underestimate the true prevalence of autism. However, the main 
goal of the system is to monitor trends over time and uncover county-specific differences to 
distribute resources and conduct research. If under-reporting is fairly consistent across counties, 
the surveillance system will still be able to meet this goal. When reporting the surveillance data, 
it would be helpful to provide information on the availability of services in the various counties 
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since areas that are underserved could result in a greater underreporting of cases. A major 
concern for this type of surveillance system would be related to consistency in interpretation of 
the diagnostic criteria. In the current CDC surveillance system, reviewers are well trained on the 
diagnostic criteria and interpret behaviors that constitute a diagnosis of ASD in a consistent 
fashion. Since there is not a biomarker available to diagnose ASDs, there is a potential for 
diagnosticians to interpret the DSM differently throughout the state, leading to a potentially 
inaccurate case count. However, there is still a great benefit to public health if the state creates a 
system that allows for ongoing monitoring of disease burden via the amount of state resources 
dedicated to treatment, educational and employment assistance, and corrections.  
By utilizing the existing state activities and the lack of laws governing surveillance for 
autism, a surveillance system could be created with the voluntary participation of these 
governmental departments. By moving from a system of occasional reporting to an ongoing 
surveillance system, state policy makers and public health professionals will be better able to 
quantify the need for services in Pennsylvania across age groups while also identifying trends in 
prevalence and geographic differences. This type of information would allow public health 
leaders in state and local governments to properly budget for autism treatment. The demographic 
information contained within these reports would allow treatment professionals to plan for 
appropriate program development. The combination of surveillance data with other data sources 
on local exposures could allow Epidemiologists to develop and test hypothesis about the etiology 
of autism. Finally, trending the number of individuals with autism that necessitate public 
assistance over time could help public health professionals evaluate the effect of interventions 
and treatments in various geographic areas.  
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